When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - FDA rejects CytoDyn's leronlimab application for HIV
CytoDyn Inc
The FDA has issued a Refusal to File letter to CytoDyn (OTCQB:CYDY) related to its marketing application seeking approval of the combination of leronlimab and HAART (highly active antiretroviral therapy) for highly treatment-experienced HIV patients.
More news on: CytoDyn Inc., Healthcare stocks news, Stocks on the move,